These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29682277)

  • 21. Effect of Medical Therapy in Allergic Rhinitis: A Systematic Review and Meta-Analysis.
    Zhang K; Li AR; Miglani A; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2022 Mar; 36(2):269-280. PubMed ID: 34546814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Impacts of Methylsulfonylmethane on Allergic Rhinitis After a Standard Allergen Challenge: Randomized Double-Blind Exploratory Study.
    Hewlings S; Kalman DS
    JMIR Res Protoc; 2018 Nov; 7(11):e11139. PubMed ID: 30497995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
    Mårtensson A; Nordström FU; Cervin-Hoberg C; Lindstedt M; Sakellariou C; Cervin A; Greiff L
    Clin Exp Allergy; 2022 Jun; 52(6):774-783. PubMed ID: 35075723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
    Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ
    Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.
    Eckman JA; Sterba PM; Kelly D; Alexander V; Liu MC; Bochner BS; Macglashan DW; Saini SS
    J Allergy Clin Immunol; 2010 Apr; 125(4):889-895.e7. PubMed ID: 19962744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis.
    Leaker BR; Scadding G; Jones CR; Barnes PJ
    Immun Inflamm Dis; 2015 Dec; 3(4):445-54. PubMed ID: 26733348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber.
    Zemelka-Wiacek M; Kosowska A; Jutel M
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization to Cat: When Is Nasal Challenge Needed?
    Al-Ahmad M; Jusufovic E; Arifhodzic N; Nurkic J; Hanoun AL
    Int Arch Allergy Immunol; 2019; 179(2):108-113. PubMed ID: 30970353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a Quail Eggs-Based Dietary Supplement for Allergic Rhinitis: Results of a Single-Arm Trial.
    Syrigou E; Psarros F; Makris M; Grapsa D; Syrigos K
    J Diet Suppl; 2021; 18(1):17-30. PubMed ID: 31762363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals.
    Shamji MH; Bellido V; Scadding GW; Layhadi JA; Cheung DK; Calderon MA; Asare A; Gao Z; Turka LA; Tchao N; Togias A; Phippard D; Durham SR
    Allergy; 2015 Feb; 70(2):171-9. PubMed ID: 25377909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of acoustic rhinometry in assessing nasal responses to cat exposure.
    Phipatanakul W; Kesavanathan J; Eggleston PA; Johnson EF; Wood RA
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):896-901. PubMed ID: 9847428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and reproducibility of nasal allergen challenge.
    Eguiluz-Gracia I; Testera-Montes A; González M; Pérez-Sánchez N; Ariza A; Salas M; Moreno-Aguilar C; Campo P; Torres MJ; Rondon C
    Allergy; 2019 Jun; 74(6):1125-1134. PubMed ID: 30667530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA
    Boelke G; Berger U; Bergmann KC; Bindslev-Jensen C; Bousquet J; Gildemeister J; Jutel M; Pfaar O; Sehlinger T; Zuberbier T
    Clin Transl Allergy; 2017; 7():33. PubMed ID: 28932387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
    Zieglmayer P; Focke-Tejkl M; Schmutz R; Lemell P; Zieglmayer R; Weber M; Kiss R; Blatt K; Valent P; Stolz F; Huber H; Neubauer A; Knoll A; Horak F; Henning R; Valenta R
    EBioMedicine; 2016 Sep; 11():43-57. PubMed ID: 27650868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appropriate Antigen Concentrations and Timing of a Nasal Provocation Test.
    Kim YH
    Yonsei Med J; 2021 Aug; 62(8):750-757. PubMed ID: 34296553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of Cat Allergy Using Controlled Methodology-A Review of the Literature and a Call to Action.
    Hossenbaccus L; Linton S; Ramchandani R; Burrows AG; Ellis AK
    Front Allergy; 2022; 3():828091. PubMed ID: 35386639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma.
    Rousseau MC; Boulay ME; Goronfolah L; Denburg J; Keith P; Boulet LP
    Allergy Asthma Clin Immunol; 2011 Apr; 7(1):8. PubMed ID: 21507261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Titration of immunotherapy by periodical nasal allergic challenges in the treatment of allergic rhinitis.
    Clarke PS
    Med J Aust; 1992 Jul; 157(1):11-3. PubMed ID: 1640882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations among visual analog scales, total nasal symptom scores, and peak nasal inspiratory flow in children with perennial allergic rhinitis.
    Boonnijasin O; Kanchanapoomi K; Srisuwatchari W; Pacharn P; Visitsunthorn N; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2024 Sep; ():. PubMed ID: 39306737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.